Cover Image
市場調查報告書

小鼠模型全球市場 (模型種類分類、專門分類、服務分類、地域分類):2015∼2023年預測

Mice Model Market (by Model Type, by Specialty, by Services, and by Geography): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

出版商 Transparency Market Research 商品編碼 339868
出版日期 內容資訊 英文 155 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
小鼠模型全球市場 (模型種類分類、專門分類、服務分類、地域分類):2015∼2023年預測 Mice Model Market (by Model Type, by Specialty, by Services, and by Geography): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
出版日期: 2015年09月03日 內容資訊: 英文 155 Pages
簡介

老鼠是擁有成熟基因工具與重要基因資源的哺乳動物常被作為模型系統。希望以小鼠為模型瞭解人類病理生理學與疾病發展過程研究、開發藥劑。基因99%與人類共通讓基因測試有新的可能性。

本報告針對全球小鼠模型市場調查、提供市場概要與至2023年預測、模型種類、用途、服務與地域分類動向、主要企業檔案。

第1章 序

第2章 摘要整理

第3章 全球小鼠模型市場概要

  • 概要
  • 小鼠模型使用者
  • 市場動向
    • 促進因素
      • 生物醫學研究的投資擴大
      • 2007∼2012年生物醫學研究成長率
      • 進化的小鼠模型增加擴大用途與接受性
      • 個人化的小鼠模型活體分析促進個人醫療小鼠模型需求
    • 市場阻礙因素
      • 全球對動物模型使用的擔憂阻礙市場
      • 代替技術發展
    • 機會
      • 亞洲各國小鼠模型市場有巨大成長機會
  • 活動影響評價
  • 市場魅力度分析
  • 競爭環境

第4章 種類分類市場

  • 概要
  • 基因轉殖小鼠模型
  • 混合/融合小鼠模型
  • 淘汰小鼠模型
  • 致癌物誘發、自然發作小鼠模型
  • 非近交系小鼠模型
  • 近交系小鼠模型
  • 移植小鼠模型
  • 調整/外科的修飾小鼠模型

第5章 專門性分類

  • 概要
  • 免疫學
  • 中樞神經系
  • 腫瘤
  • 心血管
  • 糖尿病
  • 代謝/調節性

第6章 服務分類市場

  • 概要
  • 出血、衍生服務
  • 凍結保存、回收服務
  • 檢疫服務
  • 基因測試服務

第7章 地域分類市場

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東北非
  • 其他

第8章 建議

第9章 企業檔案

  • Charles River Laboratories International, Inc
  • Crescendo Biologics Limited
  • Deltagen, Inc.
  • genOway S.A.
  • Harbour Antibodies BV
  • Harlan Laboratories, Inc.
  • ImmunoGenes AG
  • SAGE Labs
  • The Jackson Laboratory
  • Taconic Biosciences, Inc.
  • TransGenic, Inc

圖表

目錄

Mouse is a popular model system because it is a mammal with sophisticated genetic tools and significant genetic resources. The prospect of the mice as a model for exploring human pathophysiology and disease progression and for developing drugs is likely to be further widened by the introduction of new models such as immunedeficient and humanizing mouse in which human tissues and cells or genes are reconstituted. With 99% of their genes shared with humans, new possibilities were opened for genetic testing. Furthermore, the conservation of genetic association within the mice and human genomes with respect to the encoded genes and their alignment along chromosomes has been a great advantage in the identification of potentially conforming homologous mutations and disease genes.

This report studies the global mice model market from five perspectives: by type of model, application, services, and geography. Based on type of model, the market has been segmented into hybrid/congenic, transplantation mouse, transgenic, knockout, carcinogen-induced and spontaneous mouse, outbred, inbred, and conditioned/surgically modified. Based on application, the market has been segmented into immunology, central nervous system, oncology, cardiovascular, diabetes, and metabolism & regulation. Some of the prominent services offered to end-users include breeding and rederivation, cryopreservation and cryorecovery, quarantine services, genetic testing, model in-licensing, in vivo and in vitro pharmacology services, genetically engineered model services and other services such as surgical and line rescue. Geographically, the market has been studied and estimated for six regions: North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World.

The market overview section of the report demonstrates major market dynamics such as drivers, restraints, and opportunities that influence the current and future status of the industry. The market overview section includes market attractiveness analysis by geography coupled with qualitative analysis on regulatory scenarios, and impact analysis of key industry events to provide a thorough analysis of the overall competitive scenario in the global mice model market. The market overview section of the report also includes the qualitative and quantitative analysis of the competitive landscape.

Market share analysis is also provided in the market overview section of the report for 2014 in terms of value (%). The report also provides important recommendations for market players and new entrants. These recommendations would enable existing market players to expand their market share and help new companies establish their presence in the mice model market across the globe. The report concludes with the company profiles section, which includes key information about major players in the market such as financial overview, business strategies, and recent developments. Key players mentioned in the report include Charles River Laboratories, Crescendo Biologics Limited, Deltagen, Inc., GenOway S.A., Harlan Laboratories, Inc., ImmunoGenes AG, Taconic Biosciences, Inc., Lexicon Pharmaceuticals, SAGE Labs, The Jackson Laboratory, Taconic Biosciences, Inc., and TransGenic, Inc.

The global mice model market is segmented into the following categories:

Global Mice Model Market, by Type

  • Transgenic Mice Model
  • Hybrid/Congenic Mice Model
  • Knockout Mice Model
  • Carcinogen-induced and Spontaneous Mice Model
  • Outbred Mice Model
  • Inbred Mice Model
  • Transplantation Mice Model
  • Conditioned/Surgically Modified Mice Model

Global Mice Model Market, by Specialty

  • Immunology
  • Central Nervous System (CNS)
  • Oncology
  • Cardiovascular
  • Diabetes
  • Metabolism & Regulation

Global Mice Model Market, by Services

  • Breeding and Rederivation Services
  • Cryopreservation and Cryorecovery Services
  • Quarantine Services
  • Genetic Testing Services
  • Model In-licensing Services
  • In vivo and In vitro Pharmacology Services
  • Genetically Engineered Model Services
  • Other Services (Surgical and Line Rescue)

Global Mice Model Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific (APAC)
    • Japan
    • China
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & North Africa (MENA)
    • Saudi Arabia
    • UAE
    • Israel
    • Rest of MENA
  • Rest of the World (RoW)

Table of Contents

Chapter 1 - Introduction

  • 1.1. Report Description
  • 1.2. Research Methodology
    • 1.2.1. Secondary Research
    • 1.2.2. Primary Research
  • 1.3. Market Segmentation
  • 1.4. Assumptions and Stipulations

Chapter 2 - Executive Summary

  • 2.1. Global Mice Consumption, 2013
  • 2.2. Market Snapshot: Global Mice Model Market (2014 and 2023E)
  • 2.3. Global Mice Model Market, by Type, 2014 (USD Million)
  • 2.4. Global Mice Model Market, by Application, 2014 (USD Million)
  • 2.5. Global Mice Model Market, by Services, 2014 (USD Million)
  • 2.6. Comparative Analysis: Global Mice Model Market Revenue, by Geography, 2014 and 2023E (Value %)

Chapter 3 - Global Mice Model Market: Market Overview

  • 3.1. Overview
    • 3.1.1. Proportion of Mice as Compared to Total Animal Used in Research Globally (Value %), 2011
  • 3.2. End-users of Mice Models
    • 3.2.1. End-user Analysis of Mice Model Market (Value %), 2013
  • 3.3. Market Dynamics
    • 3.3.1. Drivers
      • 3.3.1.1. Growing investment in biomedical research
      • 3.3.1.2. Biomedical Research Growth Rate, 2007-2012, (%)
      • 3.3.1.3. Growing number of advanced mice model would increase applicability and acceptability
      • 3.3.1.4. Personalized in vivo analysis mice models would fuel demand for mice models in personalized medicine
    • 3.3.2. Restraints
      • 3.3.2.1. Rising concern about animal use across the globe would restrain the market
      • 3.3.2.2. Development of alternative technologies
    • 3.3.3. Opportunities
      • 3.3.3.1. Countries in Asia offer immense growth opportunities in the mice model market
  • 3.4. Event Impact Assessment: Mice Model Market
  • 3.5. Market Attractiveness Analysis: Global Mice Model Market
    • 3.5.1. Mice Model Market Analysis: The U.S. and China
    • 3.5.2. Market Attractiveness Analysis: Global Mice Model Market, by Geography
    • 3.5.3. Growth-Share Matrix Analysis: Global Mice Model Market, by Type
  • 3.6. Competitive Landscape
    • 3.6.1. Global Market Share Analysis, by Key Players, 2013 (Value %)
    • 3.6.2. Global Market Share Analysis, by Key Players, 2014 (Value %)
    • 3.6.3. Heat Map Analysis, by Key Geography, 2014 (Market Share)
    • 3.6.4. Heat Map Analysis, by Key Geography, 2014 (Market Growth)

Chapter 4 - Global Mice Model Market, by Type

  • 4.1. Overview
    • 4.1.1. Global Mice Model Market, by Type, 2013-2014 (USD Million)
    • 4.1.2. Global Mice Model Market, by Model Type, 2015E-2023E (USD Million)
  • 4.2. Transgenic Mice Model
    • 4.2.1. Transgenic Mice Applications in Various Specialties (%)
    • 4.2.2. Global Transgenic Mice Model Market, 2013-2023E (USD Million)
  • 4.3. Hybrid/Congenic Mice Model
    • 4.3.1. Global Hybrid/Congenic Mice Model Market, 2013-2023E (USD Million)
  • 4.4. Knockout Mice Model
    • 4.4.1. Knockout Mice Applications in Various Specialties, 2014 (%)
    • 4.4.2. Global Knockout Mice Model Market, 2013-2023E (USD Million)
  • 4.5. Carcinogen-induced and Spontaneous Mice Model
    • 4.5.1. Global Carcinogen-induced and Spontaneous Mice Model Market, 2013-2023E (USD Million)
  • 4.6. Outbred Mice Model
    • 4.6.1. Global Outbred Mice Model Market, 2013-2023E (USD Million)
  • 4.7. Inbred Mice Model
    • 4.7.1.1. Inbred Mice Applications in various Specialties (%), 2014
    • 4.7.1.2. Global Inbred Mice Model Market, 2013-2023E (USD Million)
  • 4.8. Transplantation Mice Model
    • 4.8.1. Global Transplantation Mice Model Market, 2013-2023E (USD Million)
  • 4.9. Conditioned/Surgically Modified Mice Model
    • 4.9.1. Global Conditioned/Surgically Modified Mice Model Market, 2013-2023E (USD Million)

Chapter 5 - Global Mice Model Market, by Specialty

  • 5.1. Overview
    • 5.1.1. Global Mice Model Market, by Application, 2013-2014 (USD Million)
    • 5.1.2. Global Mice Model Market, by Application, 2015E-2023E (USD Million)
  • 5.2. Immunology
    • 5.2.1. Global Immunology Mice Model Market, 2013-2023E (USD Million)
    • 5.2.2. Number of Immunology Mice Models, by Major Companies
    • 5.2.3. Immunology Mice Model Market Share, by Model Type, 2014
  • 5.3. Central Nervous System (CNS)
    • 5.3.1. Global CNS Mice Model Market, 2013-2023E (USD Million)
    • 5.3.2. Number of CNS Mice Models, by Major Companies
    • 5.3.3. CNS Mice Model Market Share, by Model Type, 2014
  • 5.4. Oncology
    • 5.4.1. Global Oncology Mice Model Market, 2013-2023E (USD Million)
    • 5.4.2. Number of Oncology Mice Models, by Major Companies
    • 5.4.3. Oncology Mice Model Market Share, by Model Type, 2014
  • 5.5. Cardiovascular
    • 5.5.1. Global Cardiovascular Mice Model Market, 2013-2023E (USD Million)
    • 5.5.2. Number of Cardiovascular Mice Models, by Major Companies
    • 5.5.3. Cardiovascular Mice Model Market Share, by Model Type, 2014
  • 5.6. Diabetes
    • 5.6.1. Global Diabetes Mice Model Market, 2013-2023E (USD Million)
    • 5.6.2. Number of Diabetes Mice Models, by Major Companies
    • 5.6.3. Diabetes Mice Model Market Share, by Model Type, 2014
  • 5.7. Metabolism & Regulation
    • 5.7.1. Global Metabolism & Regulation Mice Model Market, 2013-2023E (USD Million)
    • 5.7.2. Metabolism & Regulation Mice Models Market Share, by Model Type, 2014

Chapter 6 - Global Mice Model Market, by Services

  • 6.1. Overview
    • 6.1.1. Global Mice Model Market, by Services, 2013-2014 (USD Million)
    • 6.1.2. Global Mice Model Market, by Services, 2015E-2023E (USD Million)
  • 6.2. Breeding and Rederivation Services
    • 6.2.1. Global Breeding and Rederivation Services Market, 2013-2023E (USD Million)
  • 6.3. Cryopreservation and Cryorecovery Services
    • 6.3.1. Global Cryopreservation and Cryorecovery Services Market, 2013-2023E (USD Million)
  • 6.4. Quarantine Services
    • 6.4.1. Global Quarantine Services Market, 2013-2023E (USD Million)
  • 6.5. Genetic Testing Services
    • 6.5.1. Global Genetic Testing Services Market, 2013-2023E (USD Million)
  • 6.6. Model In-licensing Services
    • 6.6.1. Global Model In-licensing Market, 2013-2023E (USD Million)
  • 6.7. In vivo and In vitro Pharmacology Services
    • 6.7.1. Global In vivo and In vitro Pharmacology Services Market, 2013-2023E (USD Million)
  • 6.8. Genetically Engineered Model Services
    • 6.8.1. Genetically Engineered Model Services
  • 6.9. Other Services (Surgical and Line Rescue)
    • 6.9.1. Global Other Services Market, 2013-2023E (USD Million)

Chapter 7 - Global Mice Model Market, by Geography

  • 7.1. Overview
    • 7.1.1. Mice Model Market Share Index, 2014 (On Scale of 1 to 5)
    • 7.1.2. Global Mice Model Market, Growth Index, 2015-2023 (On a Scale of 1 to 5)
    • 7.1.3. Global Mice Model Market Revenue, by Geography, 2013-2023 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Population, GDP, and Health care Expenditure, 2011-2013
    • 7.2.2. North America Mice Model Market Revenue, 2013-2023E (USD Million
    • 7.2.3. U.S.
      • 7.2.3.1. U.S. Mice Model Market, 2013-2023E (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Comparative Analysis: Proportion of Animals Used in Research in Canada, 2011 and 2012 (Value %)
      • 7.2.4.2. Canada Mice Model Market, 2013-2023E (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Population, GDP, and Health care Expenditure, 2011-2013
    • 7.3.2. Europe Mice Model Market Revenue, 2013-2023E (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Mice Model Market Revenue, 2013-2023E (USD Million)
    • 7.3.4. U.K.
      • 7.3.4.1. U.K. Mice Model Market Revenue, 2013-2023E (USD Million)
    • 7.3.5. Rest of Europe
      • 7.3.5.1. Rest of Europe Mice Model Market Revenue, 2013-2023E (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Population, GDP, and Healthcare Expenditure, 2011-2013
    • 7.4.2. Asia Pacific Mice Model Market Revenue, 2013-2023E (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Mice Model Market, 2013-2023E (USD Million)
    • 7.4.4. China
      • 7.4.4.1. China Mice Model Market, 2013-2023E (USD Million)
    • 7.4.5. Rest of Asia Pacific
      • 7.4.5.1. Rest of Asia Pacific Mice Model Market, 2013-2023E (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Population, GDP, and Health care Expenditure, 2011 - 2013
    • 7.5.2. Latin America Mice Model Market, 2013-2023E (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Brazil Mice Model Market, 2013-2023E (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Mexico Mice Model Market, 2013-2023E (USD Million)
    • 7.5.5. Rest of Latin America
      • 7.5.5.1. Rest of Latin America Mice Model Market, 2013-2023E (USD Million)
  • 7.6. Middle East & North Africa (MENA)
    • 7.6.1. MENA Mice Model Market, 2013-2023E (USD Million)
    • 7.6.2. Saudi Arabia (KSA)
      • 7.6.2.1. Saudi Arabia Mice Model Market, 2013-2023E (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Mice Model Market, 2013-2023E (USD Million)
    • 7.6.4. Israel
      • 7.6.4.1. Israel Mice Model Market, 2013-2023E (USD Million)
    • 7.6.5. Rest of MENA
      • 7.6.5.1. Rest of MENA Mice Model Market, 2013-2023E (USD Million)
  • 7.7. Rest of the World (RoW)
    • 7.7.1. RoW Population, GDP, and Health care Expenditure, 2011-2013
    • 7.7.2. Rest of World Mice Model Market, 2013-2023E (USD Million)

Chapter 8 - Recommendations

  • 8.1. Focus on collaborations with contract research organizations or strengthening in-house research capabilities
  • 8.2. Sustaining pricing pressures in a declining global economic scenario
  • 8.3. Investing in emerging markets such as India, China, and Brazil

Chapter 9 - Company Profiles

  • 9.1. Charles River Laboratories International, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Financial Overview
    • 9.1.3. Product Portfolio
    • 9.1.4. Business Strategies
    • 9.1.5. Recent Developments
  • 9.2. Crescendo Biologics Limited
    • 9.2.1. Company Overview
    • 9.2.2. Financial Overview
    • 9.2.3. Product Portfolio
    • 9.2.4. Business Strategies
    • 9.2.5. Recent Developments
  • 9.3. Deltagen, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Overview
    • 9.3.3. Product Portfolio
    • 9.3.4. Business Strategies
    • 9.3.5. Recent Developments
  • 9.4. genOway S.A.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Overview
    • 9.4.3. Product Portfolio
    • 9.4.4. Business Strategies
    • 9.4.5. Recent Developments
  • 9.5. Harbour Antibodies BV
    • 9.5.1. Company Overview
    • 9.5.2. Financial Overview
    • 9.5.3. Product Portfolio
    • 9.5.4. Business Strategies
    • 9.5.5. Recent Developments
  • 9.6. Harlan Laboratories, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Overview
    • 9.6.3. Product Portfolio
    • 9.6.4. Business Strategies
    • 9.6.5. Recent Developments
  • 9.7. ImmunoGenes AG
    • 9.7.1. Company Overview
    • 9.7.2. Financial Overview
    • 9.7.3. Product Portfolio
    • 9.7.4. Business Strategies
    • 9.7.5. Recent Developments
  • 9.8. SAGE Labs
    • 9.8.1. Company Overview
    • 9.8.2. Financial Overview
    • 9.8.3. Product Portfolio
    • 9.8.4. Business Strategies
    • 9.8.5. Recent Developments
  • 9.9. The Jackson Laboratory
    • 9.9.1. Company Overview
    • 9.9.2. Financial Overview
    • 9.9.3. Product Portfolio
    • 9.9.4. Business Strategies
    • 9.9.5. Recent Developments
  • 9.10. Taconic Biosciences, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Overview
    • 9.10.3. Product Portfolio
    • 9.10.4. Business Strategies
    • 9.10.5. Recent Developments
  • 9.11. TransGenic, Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Financial Overview
    • 9.11.3. Product Portfolio
    • 9.11.4. Business Strategies
    • 9.11.5. Recent Developments

List of Figures

  • FIG. 1: Global Mice Model Market Segmentation
  • FIG. 2: Global Mice Model Market, By Type, 2014 (USD Million)
  • FIG. 3: Global Mice Model Market, By Application, 2014 (USD Million)
  • FIG. 4: Global Mice Model Market, By Services, 2014 (USD Million)
  • FIG. 5: Comparative Analysis: Global Mice Model Market Revenue, by Geography, 2014 and 2023E (Value %)
  • FIG. 6: Biomedical Research Growth Rate, 2007-2012, (%)
  • FIG. 7: Mice Model Market Analysis: The U.S. and China, 2014
  • FIG. 8: Market Attractiveness Analysis: Global Mice Model Market, by Geography
  • FIG. 9: Growth-Share Matrix Analysis: Global Mice Model Market, by Type
  • FIG. 10: Market Share Analysis: Global Mice Model Market, 2013 (Value %)
  • FIG. 11: Market Share Analysis: Global Mice Model Market, 2014 (Value %)
  • FIG. 12: Heat Map Analysis, by Key Geography, 2014 (Market Share)
  • FIG. 13: Heat Map Analysis, by Key Geography, 2014 (Market Growth)
  • FIG. 14: Transgenic Mice Applications in Various Specialties (%), 2014
  • FIG. 15: Transgenic Mice Model Market, 2013-2023E (USD Million)
  • FIG. 16: Hybrid/Congenic Mice Model Market, 2013-2023E (USD Million)
  • FIG. 17: Knockout Mice Applications in Various Specialties, 2014 (%)
  • FIG. 18: Knockout Mice Model Market, 2013-2023E (USD Million)
  • FIG. 19: Carcinogen-induced and Spontaneous Mice Model Market, 2013-2023E (USD Million)
  • FIG. 20: Outbred Mice Model Market, 2013-2023E (USD Million)
  • FIG. 21: Inbred Mice Applications in various Specialties (%), 2014
  • FIG. 22: Inbred Mice Model Market, 2013-2023E (USD Million)
  • FIG. 23: Transplantation Mice Model Market, 2013-2023E (USD Million)
  • FIG. 24: Conditioned/Surgically Modified Mice Model Market, 2013-2023E (USD Million)
  • FIG. 25: Immunology Mice Models Market, 2013-2023E (USD Million)
  • FIG. 26: Immunology Mice Models, by Major Companies
  • FIG. 27: Immunology Mice Model Market Share, by Model Type, 2014
  • FIG. 28: Immunology Mice Models Market, 2013-2023E (USD Million)
  • FIG. 29: Number of CNS Mice Models, by Major Companies
  • FIG. 30: Mice Model Market Share, by Model Type, 2014
  • FIG. 31: Oncology Mice Models Market, 2013-2023E (USD Million)
  • FIG. 32: Number of CNS Mice Models, by Major Companies
  • FIG. 33: Oncology Mice Model Market Share, by Model Type, 2014
  • FIG. 34: Cardiovascular Mice Models Market, 2013-2023E (USD Million)
  • FIG. 35: Number of CNS Mice Models, by Major Companies
  • FIG. 36: Cardiovascular Mice Model Market Share, by Model Type, 2014
  • FIG. 37: Diabetes Mice Models Market, 2013-2023E (USD Million)
  • FIG. 38: Number of Diabetes Mice Models, by Major Companies
  • FIG. 39: Diabetes Mice Model Market Share, by Model Type, 2014
  • FIG. 40: Metabolism & Regulation Mice Models Market, 2013-2023E (USD Million)
  • FIG. 41: Metabolism & Regulation Mice Models Market Share, by Model Type, 2014
  • FIG. 42: Global Breeding and Rederivation Services Market, 2013-2023E (USD Million)
  • FIG. 43: Global Cryopreservation and Cryorecovery Services Market, 2013-2023E (USD Million)
  • FIG. 44: Global Quarantine Services Market, 2013-2023E (USD Million)
  • FIG. 45: Global Genetic Testing Services Market, 2013-2023E (USD Million)
  • FIG. 46: Global Model In-licensing Market, 2013-2023E (USD Million)
  • FIG. 47: Global In vivo and In vitro Pharmacology Services Market, 2013-2023E (USD Million)
  • FIG. 48: Genetically Engineered Model Services
  • FIG. 49: Global Other Services Market, 2013-2023E (USD Million)
  • FIG. 50: Mice Model Market Share Index, 2014 (On Scale of 1 to 5)
  • FIG. 51: Global Mice Model Market, Growth Index, 2015-2023 (On a Scale of 1 to 5)
  • FIG. 52: U.S. Mice Model Market, 2013-2023E (USD Million)
  • FIG. 53: Comparative Analysis: Proportion of Animals Used in Research in Canada, 2011 and 2012 (Value %)
  • FIG. 54: Canada Mice Model Market, 2013-2023E (USD Million)
  • FIG. 55: Germany Mice Model Market Revenue, 2013-2023E (USD Million)
  • FIG. 56: U.K. Mice Model Market Revenue, 2013-2023E (USD Million)
  • FIG. 57: Rest of Europe Market Revenue, 2013-2023E (USD Million)
  • FIG. 58: Japan Mice Model Market, 2013-2023E (USD Million)
  • FIG. 59: China Mice Model Market, 2013-2023E (USD Million)
  • FIG. 60: Rest of Asia Pacific Mice Model Market, 2013-2023E (USD Million)
  • FIG. 61: Brazil Mice Model Market, 2013-2023E (USD Million)
  • FIG. 62: Mexico Mice Model Market, 2013-2023E (USD Million)
  • FIG. 63: Rest of Latin America Mice Model Market, 2013-2023E (USD Million)
  • FIG. 64: Saudi Arabia Mice Model Market, 2013 - 2023E (USD Million)
  • FIG. 65: UAE Mice Model Market, 2013-2023E (USD Million)
  • FIG. 66: Israel Mice Model Market, 2013-2023E (USD Million)
  • FIG. 67: Rest of MENA Mice Model Market, 2013-2023E (USD Million)
  • FIG. 68: Rest of World Mice Model Market, 2013-2023E (USD Million)
  • FIG. 69: Charles River Laboratories International, Inc.: Annual Revenue, 2012-2014 (USD Million)
  • FIG. 70: Charles River Laboratories International, Inc.: Business Segments
  • FIG. 71: Charles River Laboratories International, Inc.: Financials, 2012-2014
  • FIG. 72: Deltagen, Inc.: Annual Revenue, 2012-2014 (USD Million)
  • FIG. 73: Deltagen, Inc.: Financials, 2012-2014 (USD Million)
  • FIG. 74: genOway S.A.: Annual Revenue, 2012-2014 (USD Million)
  • FIG. 75: genOway S.A.: Financials, 2012-2014 (USD Million)
  • FIG. 76: The Jackson Laboratory: Annual Revenue, 2012-2014 (USD million)
  • FIG. 77: The Jackson Laboratory: Financials, 2012-2014 (USD million)
  • FIG. 78: TransGenic, Inc.: Annual Revenue, 2012-2014 (USD million)
  • FIG. 79: TransGenic, Inc.: Financials, 2012-2014 (USD million)

List of Tables

  • TABLE 1: Global Mice Consumption, 2013
  • TABLE 2: Market Snapshot: Global Mice Model Market (2014 and 2023E )
  • TABLE 3: Proportion of Mice as Compared to Total Animal Used in Research Globally (Value %), 2011
  • TABLE 4: End-user Analysis of Mice Model Market (Value %), 2013
  • TABLE 5: Global Mice Model Market, by Type, 2013-2014 (USD Million)
  • TABLE 6: Global Mice Model Market, by Model Type, 2015E-2023E (USD Million)
  • TABLE 7: Global Mice Model Market, by Application, 2013-2014 (USD Million)
  • TABLE 8: Global Mice Model Market, by Application, 2015E-2023E (USD Million)
  • TABLE 9: Global Mice Model Market, by Services, 2013-2014 (USD Million)
  • TABLE 10: Global Mice Model Market, by Services, 2015E-2023E (USD Million)
  • TABLE 11: Global Mice Model Market Revenue, by Geography, 2013-2023 (USD Million)
  • TABLE 12: North America Population, GDP, and Health care Expenditure, 2011-2013
  • TABLE 13: Europe Population, GDP, and Health care Expenditure, 2011-2013
  • TABLE 14: Europe Mice Model Market Revenue, 2013-2023E (USD Million)
  • TABLE 15: Asia Pacific Population, GDP, and Healthcare Expenditure, 2011-2013
  • TABLE 16: Asia Pacific Mice Model Market Revenue, 2013-2023E (USD Million)
  • TABLE 17: Latin America Population, GDP, and Health care Expenditure, 2011-2013
  • TABLE 18: Latin America Mice Model Market, 2013-2023E (USD Million)
  • TABLE 19: MENA Mice Model Market, 2013-2023E (USD Million)
  • TABLE 20: Row Population, GDP, and Health care Expenditure, 2011-2013
Back to Top